AQR Capital Management’s RxSight RXST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.92M Buy
636,129
+537,009
+542% +$4.46M ﹤0.01% 1909
2025
Q4
$1.03M Buy
99,120
+73,083
+281% +$733K ﹤0.01% 2535
2025
Q3
$234K Sell
26,037
-38,263
-60% -$336K ﹤0.01% 3190
2025
Q2
$836K Buy
64,300
+25,993
+68% +$391K ﹤0.01% 2306
2025
Q1
$967K Sell
38,307
-11,844
-24% -$352K ﹤0.01% 2032
2024
Q4
$1.72M Sell
50,151
-11,045
-18% -$498K ﹤0.01% 1610
2024
Q3
$3.02M Buy
61,196
+2,562
+4% +$131K ﹤0.01% 1291
2024
Q2
$3.53M Buy
58,634
+18,688
+47% +$1.07M 0.01% 1193
2024
Q1
$2.06M Buy
39,946
+28,683
+255% +$1.41M ﹤0.01% 1398
2023
Q4
$454K Buy
11,263
+3,257
+41% +$95.5K ﹤0.01% 1923
2023
Q3
$223K Buy
+8,006
New +$239K ﹤0.01% 2106

Other funds holding RXST

AQR Capital Management's RXST Position: Q1 2026 in Review

AQR Capital Management increased its RxSight (RXST) stake by 542% in Q1 2026, buying an estimated $4.46M and bringing the position to 636,129 shares worth $3.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1909.

AQR Capital Management first reported a position in RXST in Q3 2023 and has held it in 11 quarters since. 164 funds tracked by Wall St. Rank hold RXST as of Q1 2026.

  • AQR Capital Management held 636,129 shares of RxSight worth $3.92M as of Q1 2026.
  • AQR Capital Management bought 537,009 RxSight shares in Q1 2026, an estimated $4.46M.
  • RxSight made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #1909 holding.
  • AQR Capital Management first reported a position in RxSight in Q3 2023 and has held it in 11 quarters since.
  • 164 funds tracked by Wall St. Rank held RxSight as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.